MedTrace Logo

Ascorbic Acid Levels in MDS, AML, and CMML Patients

NCT03526666 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2019-10-03

No results posted yet for this study

Summary

This study is a non-interventional, specimen collection translational study to evaluate vitamin C levels in the peripheral blood of Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), or Chronic Myelomonocytic Leukemia (CMML) patients.

Conditions

Interventions

OTHER

Peripheral blood collection

Peripheral blood collection for the measurement of ascorbic acid levels and banking of plasma and buffy coat for future resrearch.

Sponsors & Collaborators

  • Van Andel Research Institute

    lead OTHER

Principal Investigators

  • Peter Jones, Ph.D., D.Sc. · Van Andel Research Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2018-10-31
Completion
2018-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03526666 on ClinicalTrials.gov